Lister Troy bought VERV
January 8, 2025 · Form 4 insider transaction
Lister Troy bought 40,000 shares of Verve Therapeutics Inc at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
40,000
Price
$0.00
Total value
N/A
InsiderLister Troy
RoleOfficer
SecurityRestricted Stock Units
Transaction codeA: Grant or award
Transaction dateJanuary 8, 2025
Filing dateJanuary 10, 2025
Shares owned after40,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit represents a contingent right to receive one share of common stock.; On January 8, 2025, the reporting person was granted restricted stock units, vesting in three equal annual installments, beginning on April 1, 2026, and the remaining two installments vesting on April 1, 2027 and April 1, 2028.